rs796051933
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000048.4(ASL):c.1045_1057delGTCATCTCTACGC(p.Val349fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000824 in 1,613,750 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000088 ( 0 hom. )
Consequence
ASL
NM_000048.4 frameshift
NM_000048.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.94
Genes affected
ASL (HGNC:746): (argininosuccinate lyase) This gene encodes a member of the lyase 1 family. The encoded protein forms a cytosolic homotetramer and primarily catalyzes the reversible hydrolytic cleavage of argininosuccinate into arginine and fumarate, an essential step in the liver in detoxifying ammonia via the urea cycle. Mutations in this gene result in the autosomal recessive disorder argininosuccinic aciduria, or argininosuccinic acid lyase deficiency. A nontranscribed pseudogene is also located on the long arm of chromosome 22. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-66089675-GGCGTCATCTCTAC-G is Pathogenic according to our data. Variant chr7-66089675-GGCGTCATCTCTAC-G is described in ClinVar as [Pathogenic]. Clinvar id is 203629.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-66089675-GGCGTCATCTCTAC-G is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASL | NM_000048.4 | c.1045_1057delGTCATCTCTACGC | p.Val349fs | frameshift_variant | 14/17 | ENST00000304874.14 | NP_000039.2 | |
ASL | NM_001024943.2 | c.1045_1057delGTCATCTCTACGC | p.Val349fs | frameshift_variant | 13/16 | NP_001020114.1 | ||
ASL | NM_001024944.2 | c.985_997delGTCATCTCTACGC | p.Val329fs | frameshift_variant | 12/15 | NP_001020115.1 | ||
ASL | NM_001024946.2 | c.967_979delGTCATCTCTACGC | p.Val323fs | frameshift_variant | 12/15 | NP_001020117.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASL | ENST00000304874.14 | c.1045_1057delGTCATCTCTACGC | p.Val349fs | frameshift_variant | 14/17 | 1 | NM_000048.4 | ENSP00000307188.9 | ||
ENSG00000249319 | ENST00000450043.2 | c.358_370delGTCATCTCTACGC | p.Val120fs | frameshift_variant | 5/12 | 5 | ENSP00000396527.2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152188Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
152188
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250612Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135720
GnomAD3 exomes
AF:
AC:
9
AN:
250612
Hom.:
AF XY:
AC XY:
6
AN XY:
135720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000876 AC: 128AN: 1461562Hom.: 0 AF XY: 0.0000880 AC XY: 64AN XY: 727098
GnomAD4 exome
AF:
AC:
128
AN:
1461562
Hom.:
AF XY:
AC XY:
64
AN XY:
727098
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74342
GnomAD4 genome
AF:
AC:
5
AN:
152188
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Argininosuccinate lyase deficiency Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 03, 2024 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 28, 2023 | This sequence change creates a premature translational stop signal (p.Val349Cysfs*72) in the ASL gene. RNA analysis indicates that this premature translational stop signal induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs762010471, gnomAD 0.006%). This premature translational stop signal has been observed in individuals with argininosuccinate lyase deficiency (PMID: 1705937, 16941645, 24166829). ClinVar contains an entry for this variant (Variation ID: 203629). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects ASL function (PMID: 31943503). Studies have shown that this premature translational stop signal results in skipping of exon 14 (also known as exon 13), but is expected to preserve the integrity of the reading-frame (PMID: 16941645). For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Counsyl | Aug 01, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jun 16, 2021 | Variant summary: ASL c.1045_1057del13 (p.Val349CysfsX72) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 3.6e-05 in 250612 control chromosomes (gnomAD). c.1045_1057del13 has been reported in the literature in multiple individuals affected with Argininosuccinic Aciduria (Barbosa_1991, Walker_1997, Beck_2011, Balmer_2014, Zielonka_2020). These data indicate that the variant is very likely to be associated with disease. At least one publication reports this deletion apparently causes exon skipping (Barbosa_1991). Four submitters (evaluation after 2014) cite the variant as pathogenic (n=3) and likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 22, 2024 | Frameshift variant predicted to result in abnormal protein length as the last 116 amino acid(s) are replaced with 71 different amino acid(s), and other similar variants have been reported in HGMD; Gel-based analysis of mRNA derived from patient fibroblast cells harboring c.1045_1057del found that this variant frequently results in exon skipping (PMID: 1705937); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9045711, 21710918, 31943503, 1705937) - |
Neurodevelopmental disorder Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Molecular Genetics (Pr. Bezieau's lab), CHU de Nantes | Mar 08, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at